Full 5th Circ. Redo Sought In Sanofi Chemo Hair Loss Suit

Law360 (May 5, 2021, 7:56 PM EDT) -- A Sanofi patient has asked the full Fifth Circuit to review the dismissal of her allegations the pharmaceutical giant failed to warn that its chemotherapy drug Taxotere carried a risk of permanent hair loss, arguing the panel ignored important testimony offered by her oncologist.

June Phillips requested en banc rehearing of her attempt to revive her failure-to-warn suit against Sanofi, saying in a petition filed with the court Monday that a Fifth Circuit panel's opinion in April went against both Fifth Circuit and Louisiana state law precedent on warnings causation. Phillips claims the three-judge panel wrongly set aside testimony from her oncologist Dr....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!